Suppr超能文献

用于传染病的原始人类抗体文库。

Naïve Human Antibody Libraries for Infectious Diseases.

机构信息

Institute for Research in Molecular Medicine, Universiti Sains Malaysia, Minden, Penang, Malaysia.

Analytical Biochemistry Research Centre, Universiti Sains Malaysia, Minden, 11800, Penang, Malaysia.

出版信息

Adv Exp Med Biol. 2017;1053:35-59. doi: 10.1007/978-3-319-72077-7_3.

Abstract

Many countries are facing an uphill battle in combating the spread of infectious diseases. The constant evolution of microorganisms magnifies the problem as it facilitates the re-emergence of old infectious diseases as well as promote the introduction of new and more deadly variants. Evidently, infectious diseases have contributed to an alarming rate of mortality worldwide making it a growing concern. Historically, antibodies have been used successfully to prevent and treat infectious diseases since the nineteenth century using antisera collected from immunized animals. The inherent ability of antibodies to trigger effector mechanisms aids the immune system to fight off pathogens that invades the host. Immune libraries have always been an important source of antibodies for infectious diseases due to the skewed repertoire generated post infection. Even so, the role and ability of naïve antibody libraries should not be underestimated. The naïve repertoire has its own unique advantages in generating antibodies against target antigens. This chapter will highlight the concept, advantages and application of human naïve libraries as a source to isolate antibodies against infectious disease target antigens.

摘要

许多国家在防治传染病传播方面正面临着艰巨的挑战。微生物的不断进化使问题更加严重,因为它不仅使旧的传染病重新出现,还促进了新的、更致命的变种的出现。显然,传染病导致了全球惊人的死亡率,这是一个日益严重的问题。从 19 世纪开始,人们就成功地使用从免疫动物身上收集的抗血清来预防和治疗传染病,利用抗体是一种有效的方法。抗体触发效应机制的固有能力有助于免疫系统抵御入侵宿主的病原体。免疫文库一直是传染病抗体的重要来源,因为感染后产生的库是偏倚的。即便如此,也不应低估原始抗体文库的作用和能力。原始库在针对靶抗原产生抗体方面具有独特的优势。本章将重点介绍人类原始文库作为分离针对传染病靶抗原的抗体的来源的概念、优势和应用。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/efa3/7120739/3a8016d2d426/418104_1_En_3_Fig1_HTML.jpg

相似文献

1
Naïve Human Antibody Libraries for Infectious Diseases.
Adv Exp Med Biol. 2017;1053:35-59. doi: 10.1007/978-3-319-72077-7_3.
2
Immune Human Antibody Libraries for Infectious Diseases.
Adv Exp Med Biol. 2017;1053:61-78. doi: 10.1007/978-3-319-72077-7_4.
3
Monoclonal Antibodies and Antibody Like Fragments Derived from Immunised Phage Display Libraries.
Adv Exp Med Biol. 2017;1053:99-117. doi: 10.1007/978-3-319-72077-7_6.
4
Synthetic Antibodies in Infectious Disease.
Adv Exp Med Biol. 2017;1053:79-98. doi: 10.1007/978-3-319-72077-7_5.
5
Infectious disease antibodies for biomedical applications: A mini review of immune antibody phage library repertoire.
Int J Biol Macromol. 2020 Nov 15;163:640-648. doi: 10.1016/j.ijbiomac.2020.06.268. Epub 2020 Jul 8.
6
Principles and application of antibody libraries for infectious diseases.
Biotechnol Lett. 2014 Dec;36(12):2381-92. doi: 10.1007/s10529-014-1635-x. Epub 2014 Sep 12.
7
Safety and General Considerations for the Use of Antibodies in Infectious Diseases.
Adv Exp Med Biol. 2017;1053:265-294. doi: 10.1007/978-3-319-72077-7_13.
8
Engineering Antibodies for the Treatment of Infectious Diseases.
Adv Exp Med Biol. 2017;1053:207-220. doi: 10.1007/978-3-319-72077-7_10.
9
Construction of Naive and Immune Human Fab Phage-Display Library.
Methods Mol Biol. 2018;1701:25-44. doi: 10.1007/978-1-4939-7447-4_2.
10
Immune Antibody Libraries: Manipulating The Diverse Immune Repertoire for Antibody Discovery.
Curr Pharm Des. 2016;22(43):6480-6489. doi: 10.2174/1381612822666160923111924.

引用本文的文献

1
Rapid Discovery of Potent Neutralizing Antibodies against SARS-CoV-2 through Directed Evolution of SARS-CoV-1 Antibodies.
Mol Pharm. 2025 Sep 1;22(9):5316-5328. doi: 10.1021/acs.molpharmaceut.4c01169. Epub 2025 Jul 24.
4
The Research Progress on Immortalization of Human B Cells.
Microorganisms. 2023 Dec 7;11(12):2936. doi: 10.3390/microorganisms11122936.
6
Application of recombinant antibodies for treatment of infection: Current status and future perspective.
Front Immunol. 2022 Aug 23;13:972930. doi: 10.3389/fimmu.2022.972930. eCollection 2022.
7
Methods to Produce Monoclonal Antibodies for the Prevention and Treatment of Viral Infections.
Russ J Bioorg Chem. 2022;48(2):256-272. doi: 10.1134/S1068162022020169. Epub 2022 May 26.
8
Protein Engineering: Advances in Phage Display for Basic Science and Medical Research.
Biochemistry (Mosc). 2022 Jan;87(Suppl 1):S146-S110. doi: 10.1134/S0006297922140127.
10
Protein design and variant prediction using autoregressive generative models.
Nat Commun. 2021 Apr 23;12(1):2403. doi: 10.1038/s41467-021-22732-w.

本文引用的文献

2
Beyond Helper Phage: Using "Helper Cells" to Select Peptide Affinity Ligands.
PLoS One. 2016 Sep 14;11(9):e0160940. doi: 10.1371/journal.pone.0160940. eCollection 2016.
3
Phage display-derived human antibodies in clinical development and therapy.
MAbs. 2016 Oct;8(7):1177-1194. doi: 10.1080/19420862.2016.1212149. Epub 2016 Jul 14.
4
Development and identification of fully human scFv-Fcs against Staphylococcus aureus.
BMC Immunol. 2016 Apr 29;17(1):8. doi: 10.1186/s12865-016-0146-z.
6
Protective monotherapy against lethal Ebola virus infection by a potently neutralizing antibody.
Science. 2016 Mar 18;351(6279):1339-42. doi: 10.1126/science.aad5224. Epub 2016 Feb 25.
7
Analysis of B Cell Repertoire Dynamics Following Hepatitis B Vaccination in Humans, and Enrichment of Vaccine-specific Antibody Sequences.
EBioMedicine. 2015 Nov 24;2(12):2070-9. doi: 10.1016/j.ebiom.2015.11.034. eCollection 2015 Dec.
8
Recent advances in the construction of antibody-drug conjugates.
Nat Chem. 2016 Feb;8(2):114-9. doi: 10.1038/nchem.2415. Epub 2016 Jan 4.
9
Application of streptavidin mass spectrometric immunoassay tips for immunoaffinity based antibody phage display panning.
J Microbiol Methods. 2016 Jan;120:6-14. doi: 10.1016/j.mimet.2015.11.007. Epub 2015 Nov 12.
10
Novel antibody-antibiotic conjugate eliminates intracellular S. aureus.
Nature. 2015 Nov 19;527(7578):323-8. doi: 10.1038/nature16057. Epub 2015 Nov 4.

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验